Non‐surgical treatment of hepatocellular carcinoma
Abstract
Surgical resection is currently considered to be the definitive treatment for hepatocellular carcinoma (HCC) and the only one that offers the prospect of cure or at least long‐term survival. However, most patients have unresectable disease at presentation because of poor liver function (about 75% will have underlying chronic liver disease), bilobar disease, invasion of the major vessels or overt extrahepatic metastases. The overall resectability rate for HCC is thus only 10–25% and even among those who undergo surgical resection with curative intent, there is a recurrence rate of up to 80% at 5 years 1 x [1] Nagao, T., Panis, Y., Farges, O., Benhamou, J.P., and Fekete, F. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg. 1991; 241: 114–117 Google Scholar See all References , 2 x [2] Nagao, T., Inoue, S., Yoshimi, F., Sodeyama, M., Omori, Y., and Mizuta, T. Post operative recurrence of hepatocellular carcinoma. Ann Surg. 1990; 211: 28–33 Crossref | PubMed | Scopus (201) | Google Scholar See all References , 3 x [3] Nagasue, N., Uchida, M., Makino, Y., Takemoto, Y., Yamanoi, A., and Hayashi, T. Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology. 1993; 105: 488–494 Abstract | Full Text PDF | PubMed | Scopus (16) | Google Scholar See all References . More recently there have been suggestions that other therapeutic modalities such as percutaneous ethanol injection (PEI) and radiofrequency ablation (RFA) are also potentially “curative”. It should be noted that the term “curative” in this sense is usually meant to imply “resulting in complete local control of the original lesion”. Cure in the strict and true sense of the word is seldom achieved.Keywords
This publication has 53 references indexed in Scilit:
- Risk-adapted treatment for childhood hepatoblastomaEuropean Journal of Cancer, 2004
- Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survivalHepatology, 2003
- Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trialThe Lancet, 2002
- Usefulness of intraoperative radiofrequency thermoablation of liver tumours associated or not with hepatectomyEuropean Journal of Surgical Oncology, 2000
- Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trialJournal of Hepatology, 1998
- Clinical evaluation of the partition model for estimating radiation doses from yttrium-90 microspheres in the treatment of hepatic cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 1997
- Intrahepatic Recurrence After Resection of Hepatocellular Carcinoma Complicating CirrhosisAnnals of Surgery, 1991
- Prognostic factors in the treatment of hepatocellular carcinoma with transcatheter arterial embolization and arterial infusionCancer, 1991
- Postoperative Recurrence of Hepatocellular CarcinomaAnnals of Surgery, 1990
- RADIATION HEPATITIS INDUCED BY ABDOMINAL IRRADIATION WITH THE COBALT 60 MOVING STRIP TECHNIQUEAmerican Journal of Roentgenology, 1973